New comment by Radiation Oncologist at Fox Chase Cancer Center ( July 22, 2025)
@Soha Bazyar, current ESMO guidelines (Oaknin et al., PMID 35690222) support concurrent chemoradiation (EBRT) with adjuvant chemotherapy (PORTEC-3 regimen) for all myoinvasive...